Live Breaking News & Updates on Roduct candidates

Stay informed with the latest breaking news from Roduct candidates on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Roduct candidates and stay connected to the pulse of your community

Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring

Tonix recently reported results from second positive Phase 3 trial of Tonmya™ for the management of fibromyalgia In the U.S., New Drug Application (NDA) submission to the FDA planned for the second half of 2024 In Japan, China and most countries in Europe cyclobenzaprine is a New Chemical Entity CHATHAM, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of developme

Japan , Spain , Barcelona , Comunidad-autonoma-de-cataluna , China , Zembrace-symtouch , Ben-shannon , Seth-lederman , Jessica-morris , Peter-vozzo , Drug-administration , Bio-europe-spring-convention

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q4 2023 Earnings Call Transcript

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q4 2023 Earnings Call Transcript February 28, 2024 Mersana Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to the Mersana Therapeutics Fourth Quarter 2023 Conference Call and Webcast. Currently, all […]

Brian-deschuytner , Merck-kgaa , Johnson , Merck-kga , Chief-operating , Financial-officer , Commerce-companies , Mersana-therapeutics , Nc- , Arty-huber , Ason-fredette , Roduct-candidates

Eyenovia Announces FDA Approval of Redwood City as Commercial Manufacturing Facility

Redwood City, California to complement Eyenovia’s facility in Reno, Nevada as well as its contract manufacturer, Coastline International, to produce commercial supply of Mydcombi NEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a commercial-stage ophthalmic company, today announced that the company’s facility in Redwood City, California successfully completed FDA inspection for approval as a commercial manufacturing facility. The Redwood City facility will primarily be

Redwood-city , California , United-states , Nevada , China , South-korea , Taiwan , Reno , Formosa , Eric-ribner , John-gandolfo , Norbert-lowe

Vistagen Therapeutics Inc (VTGN) Reports Fiscal 2024 Q3 Results: A Closer Look at Financials ...

VTGN's Clinical Pipeline Advances as Q3 Financials Reflect Controlled R&D Spending

Shawn-singh , Development-expenses , Vistagen-therapeutics-inc , Administrative-expenses , Ash-and-cash-equivalents , Istagen , Roduct-candidates ,

Summit Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

MENLO PARK, Calif., January 03, 2024--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that it will participate in and present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 09, 2024, at 1:30 PM PT. Robert W. Duggan, Chairman and Chief Executive Officer, and Dr. Maky Zanganeh, Chief Executive Officer and President, will provide details around the progress of our organization, including updates related to the development of our i

United-kingdom , Menlo-park , California , United-states , Australia , Canada , Japan , China , Maky-zanganeh , Robertw-duggan , Twitter , Akeso-inc

CorMedix Inc. (NASDAQ:CRMD) Q3 2023 Earnings Call Transcript

CorMedix Inc. (NASDAQ:CRMD) Q3 2023 Earnings Call Transcript November 14, 2023 CorMedix Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.21. Operator: Good afternoon, and welcome to CorMedix Third Quarter 2023 Earnings Conference Call. Today’s call is being recorded. [Operator Instructions] At this time, I would like to turn the conference over to […]

Joseph-todisco , Matt-david , Pediatric-research-equity , Pharmaceuticals-for-children , Pediatric-research-equity-act , Best-pharmaceuticals , Cormedix , Oe-todisco , Da , Eimbursement , Att-david , Hoebe-mounts

Jane Bell AM Appointed Chair of Mesoblast Audit and Risk Committee

NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that independent Director Jane Bell AM has been appointed Chair of the Mesoblast Board Audit and Risk Committee. Ms Bell joined the Board in August 2022, and is a banking and finance lawyer with 30 years of corporate finance expertise focussing on international investment transactions in the United States, Canada, Austral

Monash , South-australia , Australia , United-states , Melbourne , Victoria , London , City-of , United-kingdom , Canada , Singapore , Japan

Ascendis Pharma A/S (NASDAQ:ASND) Q2 2023 Earnings Call Transcript

Ascendis Pharma A/S (NASDAQ:ASND) Q2 2023 Earnings Call Transcript September 5, 2023 Ascendis Pharma A/S beats earnings expectations. Reported EPS is $2.16, expectations were $-2.68. Operator: Hello, and welcome to Ascendis Pharma Q2 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a […]

Germany , United-kingdom , United-states , Scott-smith , Yaron-werber , Li-watsek , Caroline-palomeque , Stina-singel , Jan-mikkelsen , Ascendis-pharma , Leland-gershell , Tim-lee

Gritstone bio and Genevant Sciences Announce Option and License Agreement

Agreement provides nonexclusive access to Genevant’s leading LNP technology for use with Gritstone bio’s self-amplifying RNA technology in wide array of infectious disease vaccines Multi-year, multi-pathogen, option-based deal follows multiple successful prior collaborations between Gritstone and Genevant EMERYVILLE, Calif., VANCOUVER, British Columbia, and BASEL, Switzerland, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims t

Switzerland , Vancouver , British-columbia , Canada , United-kingdom , British , Andrew-allen , Dan-budwick , Pete-lutwyche , Georgee-macdougall , Exchange-commission , Genevant-sciences

Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q2 2023 Earnings Call Transcript

Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q2 2023 Earnings Call Transcript August 7, 2023 Operator: Good afternoon, ladies and gentlemen and welcome to the Capricor Therapeutics Second Quarter 2023 Financial Results and Corporate Update Call. At this time all lines are in a listen-only mode. Following the presentation we’ll conduct a question-and-answer session. [Operator Instructions] As a […]

San-diego , California , United-states , Jonathan-tayco , Yushi-feng , Program-management , Life-sciences , Vice-president , Waive-life-sciences , Business-operations , Kite-pharma , Chief-financial-officer